Pages

Look Towards A New Future

Jan 10, 2012

Partnering and M&A Yearbook 2012

The Partnering and M&A Yearbook 2012 report provides comprehensive understanding and unprecedented access to the partnering and M&A deals and agreements entered into by the worlds leading healthcare companies during 2011.

Using this report, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report allows you to view all the partnering, alliances and M&A deals announced worldwide.
One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.

Understanding the flexibility of prospective partners’ negiotated deals terms provides critical insight into the negotiation process in termsof what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each parties ability to derive value from the deal.

In summary, the report provides the reader with the resources necessary to make research and understand the partnerships, alliances and M&A deals of 2011.

Partnering and M&A Yearbook

Published:January 2012

No. of Pages: 5000
Buy Now

Request Sample

Benefits
Partnering and M&A Yearbook 2012 provides the reader with the following key benefits:
  • In-depth understanding of dealmaking trends in 2011
  • Comprehensive access to over 3,500 partnering and 600 M&A deals entered into by the world’s biopharma companies during 2011
  • Detailed access to actual partnership and M&A deals and contracts entered into by the leading fifty bigpharma companies
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Scope    
Partnering and M&A Yearbook 2012 is intended to provide the reader with an in-depth understanding and access to parthering and M&A trends and structure of deals entered into by leading companies worldwide.
Partnering and M&A Yearbook 2012 includes:
  • Trends in dealmaking in the biopharma industry
  • Analysis of partnering and M&A deal structure
  • Comprehensive directory of partnering and M&A deals in 2011
  • Links to online access to over 3,500 partnering and  600 M&A deals
  • The leading partnering and M&A deals by value in 2011
  • Most active partnering and M&A dealmakers during 2011
In Partnering and M&A Yearbook 2012, the partnering and M&A deals are listed by:
  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type
Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.